| | Virus | Animal model/strain | Virus strain | Virus dose | Route(s) of infection | % lethality | Time to death (days) | Salient features | Reference |
| OW | HTNV | ICR suckling mice | 76–118 | 830 PFU/mL | i.c., i.p., i.m., and s.c. | 100 | 19-20 | Only in mice infected within 72 hrs of birth, decreasing thereafter | [177] | HTNV | ICR suckling mice | 76–118 | Serial passages of homogenized brain | i.c., i.p. | 97 | 13-14 | Mice infected 2 to 4 days after birth | [184, 185] | HTNV | BALB/c suckling mice | 76–118 | 3.8 × 103 PFU (IP), PFU (IC) | i.c., i.p. | 22.2 by both routes | 8–15 | Mice infected within 24 hrs of birth | [186] | HTNV | Striped field mice | 76–118 | 105.9 ID50 | i.m., s.c., i.p., p.o., i.l., and i.n. | 0 | N/A | Antigen, not infectious virus, and persists in lung for 1 yr | [187] | HTNV | 6–10-week-old Syrian hamsters | 76–118 | 103 PFU | i.m. | 0 | N/A | Asymptomatic infection | [188–190] | PUUV | 6–10-week-old Syrian hamsters | K27 | 1,000–2,000 PFU | i.m. | 0 | N/A | Asymptomatic infection | [46, 188, 190] | PUUV | Suckling and weanling bank voles | Hällnäs | 750–103.5 ID50 | i.c., i.m. | 0 | N/A | Asymptomatic, persistent infection | [191] | PUUV | Cynomolgus macaques | Hällnäs | 105 ID50 | i.t. | 0 | N/A | NHP exhibit lethargy, proteinuria, and microhematuria, with histopathological changes in the kidney | [192] | DOBV | 1–5-day-old NMRI suckling mice | Slovenia | 50, 500, and 5,000 FFU | i.c. | 13–88 | 18–26 | Viremia, neutralizing antibodies, and elevated levels of NO detected | [193] | DOBV | 6–8-week-old Syrian hamsters | Slovenia | 2,000 PFU | i.m. | 0 | N/A | Asymptomatic infection | [188] | SEOV | 6-day-old Lewis rats | 80–39 | 106 TCID50 | i.p. | 0 | N/A | Asymptomatic, persistent infection | [194] | SEOV | Syrian hamsters (no age specified) | 80–39 | 1,000 PFU | i.m. | 0 | N/A | Asymptomatic infection | [190] | SEOV | 70–80-day-old Norway rats | SR-11 | 10−4–106 PFU | i.p. | 0 | N/A | Asymptomatic, persistent infection | [195] | SEOV | Syrian hamsters (no age specified) | SR-11 | 1,000 PFU | i.m. | 0 | N/A | Asymptomatic infection | [196] |
| NW | ANDV | 6–8-week-old Syrian hamsters | Chile-9717869 | 2–20,000 PFU | i.m., i.n., s.c., and i.g. | Up to 100 | 10–16 IM, 10–20 IN | Recapitulates human disease in incubation time, rapid-progressing respiratory distress, and pathologic findings in the lung | [62, 197, 198] | SNV | 6–8-week-old Syrian hamsters | CC107 | 2,000–20,000 PFU | i.m. | 0 | N/A | Asymptomatic infection, no viremia, and little dissemination Hamster-adapted SNV increases dissemination | [197, 199, 200] | SNV | 6–8-week-old Syrian hamsters | CC107 | 2,000 PFU | i.m. | 100 | 10–14 | Hamsters immunosuppressed with dexamethasone and cyclophosphamide | [201] | SNV | Rhesus macaques | 77734 | 6 × 106 based on RT-PCR Ct values | i.t., i.n., p.o., and intraocular simultaneously | 70 | 15–22 | Using only deer mouse-passaged SNV | [202] | SNV | 4–6-week-old deer mice | 77734 | 5–20 ID50 | i.m. | 0 | N/A | Asymptomatic, persistent infection | [203, 204] | MAP | 4-week-old Syrian hamsters | 97021050 | 3.1 CCID50 | i.m. | 30 | 9–13 | Recapitulates human disease in incubation time, rapid-progressing respiratory distress, and pathologic findings in the lung | [205] | PHV | Cynomolgus macaques/Chimpanzee | Prospect Hill I | 107 PFU | i.v. | 0 | N/A | Mild, transient proteinuria | [206] |
|
|